DB16010Investigational
Iseganan is under investigation in clinical trial NCT00022373 (Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer).
- Code names
- Antimicrobial peptide IB-367 · IB-367
Resolves to
Compound
What you can answer from here — as of July 17, 2026
Which companies are running trials of Iseganan, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account